- Home
- BNL vs TVTX Comparison
BNL vs TVTX Comparison
Compare BNL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNL | TVTX |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNL | TVTX |
|---|---|---|
| Price | $17.57 | $35.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 15 |
| Target Price | $20.00 | ★ $37.21 |
| AVG Volume (30 Days) | 2.0M | ★ 2.0M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | ★ 6.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $447,973,000.00 | $435,826,000.00 |
| Revenue This Year | $5.32 | $108.68 |
| Revenue Next Year | $6.30 | $40.23 |
| P/E Ratio | $37.44 | ★ N/A |
| Revenue Growth | 5.49 | ★ 114.22 |
| 52 Week Low | $13.96 | $12.91 |
| 52 Week High | $18.87 | $37.50 |
Technical Indicators
Market Signals| Indicator | BNL | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 61.14 |
| Support Level | $17.47 | $34.18 |
| Resistance Level | $18.68 | $36.87 |
| Average True Range (ATR) | 0.35 | 1.86 |
| MACD | -0.06 | -0.25 |
| Stochastic Oscillator | 8.23 | 60.98 |
Price Performance
Historical ComparisonAbout BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.